Andreessen Horowitz
Listed as “Dyno Therapeutics”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Company website description: Building high-performance genetic technologies that transform patient lives.
Bio + Health
Category source ↗Checked
Some public sources are being tracked. Coverage varies by milestone.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Dyno Therapeutics”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.